A Phase I Trial of Enzastaurin (LY317615) in Combination With Carboplatin in Adults With Recurrent Gliomas
Latest Information Update: 30 Aug 2013
At a glance
- Drugs Enzastaurin (Primary) ; Carboplatin
- Indications Anaplastic astrocytoma; Glioblastoma; Glioma; Oligodendroglioma; Primitive neuroectodermal tumours
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Eli Lilly and Company
- 01 Jul 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Jul 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 Jun 2013 Planned End Date changed from 1 Dec 2010 to 1 Jul 2013 as reported by ClinicalTrials.gov.